
Signaling Pathways in Cancer Pathogenesis and Therapy
Kurzinformation



inkl. MwSt. Versandinformationen
Artikel zZt. nicht lieferbar
Artikel zZt. nicht lieferbar

Beschreibung
In recent years, increasing evidence has suggested that abnormal activation of signaling pathways is a critical event in cancer pathogenesis. In particular, activation of these pathways can lead to inappropriate cellular survival, proliferation, pluripotency, invasion, metastasis, and angiogenesis. Thus, understanding the mechanisms by which signaling pathways become subverted in a cancer cell can provide insight into critical events in cancer pathogenesis. Furthermore, as our ability to target specific molecular interactions advances, we now have the ability to design small molecules, protein therapeutics, and other forms of targeted therapies. By focusing on the specific molecular abnormalities in a cancer cell, these agents hold the potential to be much more effective and much less toxic than current cytotoxic therapies. von David, Frank
Produktdetails

So garantieren wir Dir zu jeder Zeit Premiumqualität.
Über den Autor
- Hardcover
- 192 Seiten
- Erschienen 2013
- Springer
- Gebunden
- 276 Seiten
- Erschienen 2013
- Springer
- Gebunden
- 412 Seiten
- Erschienen 2010
- Humana
- hardcover
- 1822 Seiten
- Erschienen 2011
- Wiley-VCH
- hardcover
- 991 Seiten
- Erschienen 2006
- Wiley-VCH
- hardcover
- 821 Seiten
- Erschienen 2002
- McGraw Hill Higher Education
- Gebunden
- 561 Seiten
- Erschienen 2022
- Thieme
- Gebunden
- 231 Seiten
- Erschienen 2013
- S. Karger
- perfect
- 168 Seiten
- Erschienen 1979
- Fischer Verlag